SAREPTA THERAPEUTICS INC - NOTE 1.250% 9/1

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Debt / NOTE 1.250% 9/1
Number of holders
57
Total 13F principal, excl. options
1,009,456,484
Principal change
+12,708,116
Total reported value, excl. options
$771,135,004
Value change
-$30,695,954
Number of buys
34
Number of sells
-53
Price
$0.7338

Significant Holders of SAREPTA THERAPEUTICS INC - NOTE 1.250% 9/1 as of Q2 2025

95 filings reported holding 803607AD2 - SAREPTA THERAPEUTICS INC - NOTE 1.250% 9/1 as of Q2 2025.
SAREPTA THERAPEUTICS INC - NOTE 1.250% 9/1 has 57 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of $1,009,456,484 of principal .
Largest 10 bondholders include Linden Advisors LP ($284,547,000 of principal), Davidson Kempner Capital Management LP ($80,000,000 of principal), WHITEBOX ADVISORS LLC ($56,000,000 of principal), DeepCurrents Investment Group LLC ($51,500,000 of principal), TENOR CAPITAL MANAGEMENT Co., L.P. ($47,500,000 of principal), Balyasny Asset Management L.P. ($43,500,000 of principal), Nuveen, LLC ($40,000,000 of principal), HIGHBRIDGE CAPITAL MANAGEMENT LLC ($40,000,000 of principal), Calamos Advisors LLC ($37,821,000 of principal), and READYSTATE ASSET MANAGEMENT LP ($25,000,000 of principal).
This table shows the top 57 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.